Toronto Dominion Bank
TCRT icon

Toronto Dominion Bank’s Alaunos Therapeutics TCRT Stock Holding History

Toronto Dominion Bank’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$1K – 1261
2017
Q1 		$1K Hold
1
– – ﹤0.01% 1179
2016
Q4 		$1K Hold
1
– – ﹤0.01% 1200
2016
Q3 		$1K Hold
1
– – ﹤0.01% 1179
2016
Q2 		$1K Hold
1
– – ﹤0.01% 1168
2016
Q1 		$1K Hold
1
– – ﹤0.01% 1194
2015
Q4 		$1K Hold
1
– – ﹤0.01% 1039
2015
Q3 		$1K Hold
1
– – ﹤0.01% 1025
2015
Q2 		$2K Buy
+1
New +$1.55K ﹤0.01% 1060

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank's TCRT Position: Q2 2017 in Review

Toronto Dominion Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2017, closing a stake of 1 share — an estimated $1K sold.

Toronto Dominion Bank first reported a position in TCRT in Q2 2015 and held it in 8 quarters. The position peaked at $2K in Q2 2015. 122 funds tracked by Wall St. Rank hold TCRT as of Q2 2017.

  • Toronto Dominion Bank reported no remaining Alaunos Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Toronto Dominion Bank sold 1 Alaunos Therapeutics share in Q2 2017, an estimated $1K.
  • Toronto Dominion Bank first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 8 quarters.
  • Toronto Dominion Bank's Alaunos Therapeutics position peaked at $2K in Q2 2015.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2017.

Based on Toronto Dominion Bank's 13F filing for Q2 2017, filed 18 Aug 2017.